• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Novartis

Patientory Launches Blockchain App Enabling Patients to Earn Money for Their Health Data

by Syed Hamza Sohail 04/05/2023 Leave a Comment

Patientory Launches Blockchain App Enabling Patients to Earn Money for Their Health Data

What You Should Know: Patientory Inc., the creator of a blockchain-based, HIPAA-compliant, private medical data ecosystem, announced today that it has launched two solutions–Patientory Consumer Decentralized Application-designed to help patients more efficiently and securely store and earn money from their medical data and Neith Enterprise Dashboard in partnership with Prosper Healthtech, a community-backed organization committed to equity in Birmingham offering a supportive network of
Read More

23andMe, Novartis Launches Pilot for Lipoprotein(a) Education

by Jasmine Pennic 03/24/2023 Leave a Comment

23andMe to Mine Genetic Data for Drug Discovery

What You Should Know: - In support of Lipoprotein(a) Awareness Day, 23andMe, a human genetics and biopharmaceutical company, today announced a collaboration with Novartis to increase awareness for Lipoprotein(a) (Lp(a)). - High levels of Lp(a) are associated with increased risk of heart attack, stroke and other life threatening conditions. The level of Lp(a), which can be detected through a simple blood test, is almost entirely determined by genes and is unrelated to diet, exercise or
Read More

The Gains and Pains of Using AI in the Pharmaceutical Industry

by Michael Galarnyk, AI Evangelist at cnvrg.io 10/25/2022 Leave a Comment

The Gains and Pains of Using AI in the Pharmaceutical Industry

The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million. Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most
Read More

Eclipse and Mayo Clinic Create Nucleus RadioPharma for  Cancer Patients

by Syed Hamza Sohail 10/14/2022 Leave a Comment

Eclipse and Mayo Clinic Create Nucleus RadioPharma for Cancer Patients

What You Should Know: - Eclipse, a venture capital firm investing in the digital transformation of the world's physical industries, and Mayo Clinic, a leading nonprofit health organization, recently announced the creation and seed funding of Nucleus RadioPharma, a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new
Read More

Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs

by Jasmine Pennic 09/20/2022 Leave a Comment

Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs

What You Should Know: - Lyfegen, a global health tech SaaS company driving the world’s transition from volume to value-based healthcare for high-cost drugs raises $8M in Series A financing round led by aMoon, with additional participation from APEX Ventures and others. - Lyfegen’s value-based contracting software is used by healthcare payers and leading pharma companies, including Novartis, Roche, MSD, Bristol Myers Squibb (BMS) and Johnson & Johnson. Value-Based
Read More

H1 Adds $20M to Series C to Power Democratization of Global Healthcare Data

by Jasmine Pennic 06/09/2022 Leave a Comment

H1 Raises $100M to Expand Healthcare Professional Data Network

What You Should Know: - H1, the connecting force for global healthcare professional, clinical, science, and research information, announced their Series C extension led by Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital and Novartis Pharma AG, bringing the total Series C raise to over $120M.  - The news comes at a time when public markets are down and many other companies are doing down rounds. The extension allows H1’s valuation of $773M to stay constant,
Read More

Flywheel Nabs $15M for Next-Gen Informatics Platform for Medical Research & Collaboration

by HITC Staff 02/03/2021 Leave a Comment

Flywheel Nabs $15M for Next-Gen Informatics Platform for Medical Research & Collaboration

What You Should Know: - Minneapolis-based digital health startup Flywheel raies $15M in Series B funding to advance the use of AI in clinical trials co-led by Beringea and 8VC including participation from Novartis dRx Capital, Hewlett Packard Enterprise (HPE), Great North Labs, iSelect and Argonautic Ventures. - By leveraging cloud scalability and automating research workflows, Flywheel helps organizations scale research data and analysis, improve scientific collaboration and
Read More

H1 Secures $58M to Expand Global Healthcare Data Platform

by Fred Pennic 12/17/2020 Leave a Comment

H1 Closes $58 Million Series B Co-Led by IVP and Menlo Ventures

What You Should Know: - H1, the largest database of information on every doctor in the world raises $58M in Series B funding, just six months after raising its Series A round during the pandemic. - H1 is the largest database in the world connecting that provides comprehensive in-depth profiles of more than 9 million healthcare professionals and 16,000 institutions in 70-plus countries, all of which are kept up-to-date weekly.  H1, a global platform for the healthcare
Read More

Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics

by Jasmine Pennic 12/08/2020 Leave a Comment

Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics

What You Should Know: - Pear Therapeutics today announced that it has successfully closed an $80 million Series D financing led by SoftBank Vision Fund 2. -  Pear is the leader in prescription digital therapeutics and the first company to receive FDA authorization for a prescription digital therapeutic (PDT) to treat disease. - Pear currently has three FDA authorized therapies, reSET, reSET-O and Somryst, for substance use disorder, opioid use disorder, and chronic insomnia,
Read More

Cerner Invests in Xealth to Jointly Develop Digital Health Solutions for Clinicians

by Fred Pennic 08/06/2020 Leave a Comment

Digital Prescribing Platform Xealth Raises $11M to Expand Digital Health Tools

What You Should Know: - Cerner and Xealth announce a collaboration to foster tighter physician-patient relationships by giving patients easier access to digital health tools. - These assets will be prescribed directly within the physician’s EHR workflow to manage conditions including chronic diseases, behavioral health, maternity care, and surgery preparation. - Cerner and LRVHealth have together invested $6 million in Xealth as part of this agreement, with Cerner and Xealth planning
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

5 Ways New Trump Administration Tariffs Are Impacting U.S. Healthcare Now

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI

RadNet to Acquire iCAD for $103M in All-Stock Transaction

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |